checkAd

     319  0 Kommentare Lack of early-stage partnering and collaboration is inhibiting pharma innovation in Asia-Pacific, says Cortellis report - Seite 2

    Japan

    4.

    Astellas Pharma Inc

    Japan

    5.

    Otsuka Holdings Co Ltd

    Japan

    6.

    Shionogi & Co Ltd

    Japan

    6.

    CSL Ltd

    Australia

    8.

    Ono Pharmaceutical Co Ltd

    Japan

    9.

    Mitsubishi Chemical Holdings Corp

    Japan

    9.

    Kirin Holdings Co Ltd

    Japan

    *Top-Tier is defined as larger, more established companies that have launched 10 or more products.

    The top 10 most innovative Small and Medium Enterprises:

    Rank

    Company

    Country/Region

    1.

    Lee's Pharmaceutical Holdings Ltd

    Hong Kong

    2.

    Takara Holdings Inc

    Japan

    3.

    Jiangsu Hengrui Medicine Co Ltd

    Mainland China

    4.

    Seite 2 von 4



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Lack of early-stage partnering and collaboration is inhibiting pharma innovation in Asia-Pacific, says Cortellis report - Seite 2 New report shows APAC is poised to take bigger slice of pharma market with nearly 6,000 drugs in active development, but obstacles to innovation are inhibiting regional companies from achieving their full potential LONDON and PHILADELPHIA, Aug. …